Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel

US12168718B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12168718-B2
Application numberUS-202117348157-A
CountryUS
Kind codeB2
Filing dateJun 15, 2021
Priority dateJul 22, 2016
Publication dateDec 17, 2024
Grant dateDec 17, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Block copolymers have a general chemical structure of one of the formulas [A] n -[B] m and [B] n -[A] m , wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.

First claim

Opening claim text (preview).

The invention claimed is: 1. A thermoresponsive hydrogel comprising an aqueous solution of a block copolymer having a general chemical structure of one of the following formulas: [A] n -[B] m or [B] n -[A] m wherein block [A] of the block copolymer is chosen from the group consisting of 2-n-propyl-2-oxazine, 2-cyclopropyl-2-oxazine, and 2-butyl-2-oxazine, wherein block [B] of the block copolymer is chosen from the group consisting of 2-methyl-2-oxazoline and 2-ethyl-2-oxazoline, wherein n is in the range of 20 to 300, wherein m is in the range of 20 to 300, and wherein n and m have the same or approximately the same value, and wherein the block copolymer is at a concentration of at least 18 wt. % in the aqueous solution to form the thermoresponsive hydrogel. 2. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer is prepared by a two-stage co-polymerization. 3. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of one of the following formulas: wherein R is an alkyl group and R 1 is a piperdine group, wherein n is in the range of 20 to 300, wherein m is in the range of 20 to 300, and wherein n and m have the same or approximately the same value. 4. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of the formula: wherein n and m each have a value of 50. 5. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of the following formula: wherein n and m each have a value of 100. 6. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer gels at a temperature above 10° C. 7. The thermoresponsive hydrogel according to claim 6 , wherein the block copolymer gels at a temperature above 25° C. 8. The thermoresponsive hydrogel according to claim 7 , wherein the block copolymer gels at a temperature above 30° C. 9. The thermoresponsive hydrogel according to claim 8 , wherein the block copolymer gels at a temperature above 35° C. 10. A composition which comprises an active ingredient and the thermoresponsive hydrogel according to claim 1 as a carrier material for the active agent. 11. The composition according to claim 10 , wherein the active agent is embedded in the carrier material. 12. The composition according to claim 11 , wherein the carrier material is characterized by time-delayed release or distribution of the active ingredient. 13. A drug delivery system which comprises a drug or drugs and the thermoresponsive hydrogel according to claim 1 as a carrier material for the drug or drugs. 14. The drug delivery system of claim 13 , wherein the carrier material is characterized by time-delayed release or distribution of the drug or drugs. 15. A composition which comprises cells and the thermoresponsive hydrogel according to claim 1 as a carrier material for the cells. 16. A composition which comprises one or more proteins and the thermoresponsive hydrogel according to claim 1 as a carrier material for the one or more proteins. 17. A block copolymer which has a general chemical structure of the formula: wherein n and m each have a value of 50. 18. A block copolymer which has a general chemical structure of the following formula: wherein n and m each have a value of 100. 19. The thermoresponsive hydrogel according to claim 1 , further comprising a phosphate buffer saline. 20. The thermoresponsive hydrogel according to claim 1 , further comprising one or more members selected from the group consisting of a drug, a protein, and cells.

Assignees

Inventors

Classifications

  • having a macromolecular matrix · CPC title

  • containing added animal cells (organs or tissue containing native cells A61L27/36) · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes · CPC title

  • Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12168718B2 cover?
Block copolymers have a general chemical structure of one of the formulas [A] n -[B] m and [B] n -[A] m , wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.
Who is the assignee on this patent?
Julius Maximilians—Universitaet Wuerzburg, Univ Wuerzburg J Maximilians
What technology area does this patent fall under?
Primary CPC classification C08G73/0233. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).